Loading clinical trials...

NOT_YET_RECRUITINGNA

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and Platelet-Rich Fibrin: Randomized Controlled Trial

NCT07079917•Fayoum University

View on ClinicalTrials.gov

Summary

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width.
•Minimum vertical height of 8 mm.
•Gingival tissue of healthy adequate keratinization, more than 2mm.

Exclusion Criteria

•The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing
•Radiotherapy to the head and neck region
•Chemotherapy within the last 12 months
•Uncontrolled periodontitis
•Smoking
•Bisphosphonate therapy
•Pregnancy
•Presence of periapical infection or lesion

Locations (1)

Fayoum University

Al Fayyum, Egypt

Key Dates

Start Date

August 1, 2025

Primary Completion Date

August 21, 2025

Completion Date

June 21, 2026

Last Updated

July 23, 2025

Enrollment

ESTIMATED participants

Conditions

Alveolar Bone Loss

Interventions

subperiosteal tunneling for horizontal alveolar ridge augmentation

PROCEDURE

conventional alveolar ridge augmentation

PROCEDURE

Composite Plug Vs D-PTFE Membrane in Socket Preservation

NCT06315413

Alveolar Bone Loss

View study

RECRUITINGPHASE4

Evaluation of Erythropoietin on Alveolar Ridge Preservation

NCT06513039

Alveolar Bone Loss

View study

ACTIVE_NOT_RECRUITINGPHASE3

Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants

NCT07047131

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

Inclusion Criteria

Exclusion Criteria

Composite Plug Vs D-PTFE Membrane in Socket Preservation

Evaluation of Erythropoietin on Alveolar Ridge Preservation

Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants

Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition

Accuracy Assessment of Chin Graft for Ridge Augmentation Using Tooth-supported Guide Versus Free Hand Technique

Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting